查看购物车
  • Traditional Chinese
  • English
  • Japanese
非类固醇抗发炎药市场规模及预测（2021-2031年），全球及区域份额、趋势和成长机会分析报告涵盖：药物类别、给药途径、适应症、配销通路和地理
市场调查报告书
商品编码
1858569

非类固醇抗发炎药市场规模及预测（2021-2031年），全球及区域份额、趋势和成长机会分析报告涵盖：药物类别、给药途径、适应症、配销通路和地理

Non-steroidal Anti-Inflammatory Drugs Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Drug Class, Route Of Administration, Indication, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 273 Pages | 订单完成后即时交付

价格

非类固醇抗发炎药 (NSAID) 市场规模预计将从 2024 年的 248.2 亿美元成长到 2031 年的 383.8 亿美元；预计 2025 年至 2031 年期间，该市场将以 6.5% 的复合成长率年增长。

推动市场成长的主要因素包括慢性疼痛疾病和发炎性疾病（如关节炎和头痛）的日益普遍，以及非鸦片类非类固醇抗发炎药物（NSAIDs）的广泛应用。此外，NSAIDs使用中的个人化和精准医疗方法也可能在预测期内促进非类固醇抗发炎药市场的成长。然而，日益增多的监管和研发壁垒是阻碍市场发展的因素之一。

根据世界卫生组织的数据，2019年全球约有5.28亿人患有骨关节炎，这一数字比1990年翻了一番还多。值得注意的是，73%的骨关节炎患者年龄超过55岁，其中女性占60%。 2020年，全球有6.19亿人患有腰痛，预计到2050年，数字可能上升至8.43亿。

非类固醇抗发炎药 (NSAIDs) 被广泛用于治疗骨关节炎、肌肉损伤、头痛和神经病变等疾病引起的疼痛。随着全球人口老化和慢性发炎性疾病的日益普遍，对有效疼痛管理方案的需求持续增长。 NSAIDs 是一种经证实有效的疼痛和发炎治疗方法。为此，製药公司不断创新，研发新的 NSAID 製剂以满足不同患者的需求。例如，2023 年 1 月，VaroJ Pharma 推出了其 1.3% 双氯芬酸依泊胺外用系统，这是 IBSA Pharma 公司 Flector（双氯芬酸依泊胺）的授权仿药，专门用于治疗肌肉拉伤、扭伤和挫伤引起的急性疼痛。

此外，癌症治疗的最新进展提高了癌症患者的存活率，同时也导致化疗引起的周边神经病变（CIPN）等慢性疼痛疾病的发生率增加。根据2025年1月发表在《区域麻醉与疼痛医学》杂誌上的一项荟萃分析，CIPN影响约41.2%的慢性疼痛患者，其中接受铂类或紫杉烷类化疗的患者发病率显着更高——肺癌患者的发病率高达60.26%。神经损伤引起的神经性疼痛，以及肌肉骨骼和发炎性疾病，正在大幅扩大非类固醇抗发炎药物（NSAIDs）及相关镇痛药的市场。

因此，对非类固醇抗发炎药 (NSAID) 治疗常见慢性疾病的需求不断增长，推动了非类固醇抗发炎药 (NSAID) 市场的成长。

本报告透过比较公司分析，基于产品组合（产品满意度、产品特性和可用性）、近期市场发展（併购、新产品上市及改进、投资及融资、奖项、协议、合作与伙伴关係、认可和扩张）以及地域分布，对非类固醇抗发炎药 (NSAID) 市场预测进行评估和分类，从而帮助企业更好地进行决策并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争格局并更好地进行并了解竞争格局并了解竞争格局并了解竞争格局并了解竞争并更好地进行竞争格局并了解竞争格局。报告深入探讨了全球非类固醇抗发炎药物 (NSAID) 市场领先供应商近期取得的重大进展和创新。主要市场参与者包括：辉瑞 (B Pfizer)、拜耳 (Bayer AG)、格兰马克製药有限公司 (Glenmark Pharmaceuticals Ltd.)、瑞迪博士实验室有限公司 (Dr. Reddy's Laboratories Ltd)、勃林格殷格翰国际工业有限公司 (Novarce Island AG)、希克玛製药 (Hikma Pharmaceuticals) 和维亚特里斯公司 (Viatris Inc.)。

依药物类别划分，市场可分为非选择性非类固醇抗发炎药（NSAIDs）和COX-2选择性NSAIDs。 2024年，非选择性NSAIDs占据了最大的市场份额，预计在2025年至2031年期间将保持最高的复合年增长率（CAGR）。

依给药途径划分，非类固醇抗发炎药（NSAID）市场可分为口服、注射和外用。 2024年，口服製剂占了非类固醇抗发炎药（NSAID）市场最大的份额，预计在2025年至2031年期间将维持较高的复合年增长率。

从适应症来看，非类固醇抗发炎药（NSAID）市场可分为关节炎、偏头痛、眼科疾病和其他疾病。 2024年，关节炎领域在非类固醇抗发炎药物（NSAID）市场中占据主导地位，预计在2025年至2031年期间将维持最高的复合年增长率。

根据配销通路，非类固醇抗发炎药 (NSAID) 市场可分为医院药房、零售药房和线上管道。 2024 年，零售药局占据了 NSAID 市场最大的份额。医院药局在慢性病管理和确保患者获得价格合理的药物方面发挥着日益重要的作用。医院药局在为住院患者和出院手术患者提供处方 NSAID 方面发挥着至关重要的作用。在这些场所，专业的监管确保了安全有效的镇痛，尤其是在使用更新、更强效的注射剂型时。推动这一成长的最新创新包括固定剂量偏头痛治疗药物，例如美洛昔康联合利扎曲坦，以及旨在降低成本和提高可及性的生物相似药 NSAID 的推出。此外，个人化医疗的兴起，即使用旨在最大限度减少副作用的靶向 NSAID，正在促进其在医院环境中的广泛应用，因为在医院环境中，医生的密切监测至关重要。这些因素导致对非类固醇抗发炎药的需求增加，并透过医院药房在全球范围内扩大其分销。

在非类固醇抗发炎药 (NSAID) 市场营运的公司采用了多种有机成长和无机成长策略。有机成长策略主要包括产品上市和产品核准。无机成长策略则包括收购、合作和伙伴关係。这些成长策略使市场参与者能够拓展业务、增强地理覆盖，并促进整体市场成长。此外，收购和伙伴关係等策略也有助于巩固客户基础并扩展产品组合。

目录

第一章：引言

第二章：执行概要

  • 分析师市场展望

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：
  • 假设和局限性

第四章：非类固醇抗发炎药（NSAID）市场概况

  • PEST分析

第五章：非类固醇抗发炎药（NSAID）市场－主要市场动态

  • 非类固醇抗发炎药（NSAID）市场－主要市场动态
  • 市场驱动因素
    • 慢性疼痛疾病和发炎性疾病的盛行率不断上升
    • 非类固醇抗发炎药作为非鸦片类镇痛药的偏好转变
  • 市场限制
    • 监管和发展障碍
  • 市场机会
    • 市场参与者的策略性倡议
  • 未来趋势
    • 非类固醇抗发炎药物使用中的个人化和精准医疗方法
  • 驾驶员和安全带的影响：

第六章：非类固醇抗发炎药（NSAID）市场－全球市场分析

  • 2021-2031年非类固醇抗发炎药（NSAID）市场收入
  • 非类固醇抗发炎药（NSAID）市场预测分析

第七章：非类固醇抗发炎药（NSAID）市场分析－依药物类别划分

  • 非选择性非类固醇抗发炎药
  • COX-2选择性非类固醇抗发炎药

第八章：非类固醇抗发炎药（NSAID）市场分析－依给药途径划分

  • 口服
  • 注射剂
  • 主题

第九章：非类固醇抗发炎药（NSAID）市场分析－依适应症划分

  • 关节炎
  • 偏头痛
  • 眼科疾病
  • 其他的

第十章：非类固醇抗发炎药（NSAID）市场分析－依配销通路划分

  • 医院药房
  • 零售药局
  • 线上管道

第十一章：非类固醇抗发炎药（NSAID）市场－地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十二章：竞争格局

  • 关键参与者热力图分析
  • 公司市占率分析，2024 年

第十三章：行业概况

  • 扩张
  • 新产品开发
  • 其他商业策略

第十四章：公司简介

  • Pfizer Inc
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Hikma Pharmaceuticals Plc
  • Boehringer Ingelheim International GmbH
  • Viatris Inc
  • Haleon Plc

第十五章：附录

Product Code: TIPRE00004421

The nonsteroidal anti-inflammatory drugs (NSAID) market size is projected to rise from US$ 24.82 billion in 2024 to US$ 38.38 billion by 2031; the market is expected to register a CAGR of 6.5% during 2025-2031.

Major factors propelling the market growth include the increasing prevalence of chronic pain disorders and inflammatory conditions such as arthritis and headaches, and the surging adoption of non-opioid NSAIDs. Further, the personalized and precision medicine approaches in NSAIDS use will likely boost the nonsteroidal anti-inflammatory drugs (NSAID) market growth during the forecast period. However, the increasing regulatory and development barriers is among the market deterrents.

According to the World Health Organization, approximately 528 million people globally were affected by osteoarthritis in 2019-a figure that has more than doubled since 1990. Notably, 73% of osteoarthritis sufferers are over the age of 55, and females account for 60% of this population. In 2020, 619 million individuals worldwide experienced lower back pain, with projections indicating this number could rise to 843 million by 2050.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed for managing pain associated with conditions such as osteoarthritis, muscle injuries, headaches, and neuropathies. As the global population ages and chronic inflammatory diseases become more prevalent, the demand for effective pain management solutions continues to grow. NSAIDs offer a proven and efficient method for treating pain and inflammation. In response, pharmaceutical companies are innovating with new NSAID formulations to address diverse patient needs. For example, in January 2023, VaroJ Pharma launched its diclofenac epolamine topical system 1.3%, the authorized generic of IBSA Pharma's Flector (diclofenac epolamine), designed specifically for treating acute pain from strains, sprains, and contusions.

Moreover, recent advances in cancer therapies have led to a rise in cancer survivorship, accompanied by an increase in chronic pain conditions such as chemotherapy-induced peripheral neuropathy (CIPN). Based on a meta-analysis published in Regional Anesthesia and Pain Medicine in January 2025, CIPN affects around 41.2% of chronic pain patients, with notably higher rates among those undergoing platinum or taxane-based chemotherapy-60.26% prevalence in lung cancer patients. Neuropathic pain resulting from nerve damage, combined with musculoskeletal and inflammatory conditions, is substantially expanding the market for NSAIDs and related analgesics.

Therefore, the demand of NSAIDs for the treatment of prevalent chronic diseases is increasing the nonsteroidal anti-inflammatory drugs (NSAID) market growth.

The comparative company analysis evaluates and categorizes the nonsteroidal anti-inflammatory drugs (NSAID) market forecast based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global nonsteroidal anti-inflammatory drugs (NSAID) market. The key market players are B Pfizer, Bayer AG, Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd, Boehringer Ingelheim International GmbH, Haleon plc, Sun Pharmaceutical Industries Ltd, Novartis AG, Hikma Pharmaceuticals, Viatris Inc.

By drug class, the market is segmented into nonselective NSAIDS and cox-2 selective NSAIDs. The nonselective NSAIDS segment held the largest nonsteroidal anti-inflammatory drugs (NSAID) market share in 2024 and is expected to register the highest CAGR during 2025-2031.

By route of administration, the nonsteroidal anti-inflammatory drugs (NSAID) market is classified into oral, injectable and topical. The oral segment held the largest share of the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024 and is expected to register a higher CAGR during 2025-2031.

In terms of indication, the nonsteroidal anti-inflammatory drugs (NSAID) market is segmented into arthritis, migraine, ophthalmic diseases, and others. The arthritis segment dominated the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024 and is anticipated to register the highest CAGR during 2025-2031.

The market, based on distribution channel, is segmented into hospital pharmacies, retail pharmacies and online channels. The retail pharmacies segment held the largest share of the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024. Hospital pharmacies are playing an increasingly prominent role in managing chronic diseases and ensuring access to affordable medications. Hospital pharmacies play a crucial role in providing prescription NSAIDs to inpatients and discharged surgical patients. Professional oversight in these settings ensures safe and effective pain relief, particularly with newer and more potent injectable formulations. Recent innovations driving this growth include fixed-dose migraine treatments, such as meloxicam combined with rizatriptan, as well as the introduction of biosimilar NSAIDs aimed at reducing costs and increasing accessibility. Moreover, the shift toward personalized medicine, which involves targeted NSAIDs designed to minimize side effects, is promoting greater adoption in hospital environments, where close physician monitoring is essential. These factors are contributing to increased demand for NSAIDs and expanding their distribution through hospital pharmacies globally.

Various organic and inorganic strategies are adopted by companies operating in the nonsteroidal anti-inflammatory drugs (NSAID) market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Landscape

  • 4.1 PEST Analysis

5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Key Market Dynamics

  • 5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Chronic Pain Disorders and Inflammatory Diseases
    • 5.2.2 Shifting Preference for NSAIDs as Non-Opioid Pain Management
  • 5.3 Market Restraints
    • 5.3.1 Regulatory and Development Barriers
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Personalized and Precision Medicine Approaches in NSAIDs Use
  • 5.6 Impact of Drivers and Restraints:

6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Global Market Analysis

  • 6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021-2031
  • 6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast Analysis

7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Drug Class

  • 7.1 Non-Selective NSAIDs
    • 7.1.1 Overview
    • 7.1.2 Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 COX-2 Selective NSAIDs
    • 7.2.1 Overview
    • 7.2.2 COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Injectable
    • 8.2.1 Overview
    • 8.2.2 Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Topical
    • 8.3.1 Overview
    • 8.3.2 Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Indication

  • 9.1 Arthritis
    • 9.1.1 Overview
    • 9.1.2 Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Migraine
    • 9.2.1 Overview
    • 9.2.2 Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Ophthalmic Diseases
    • 9.3.1 Overview
    • 9.3.2 Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Retail Pharmacies
    • 10.2.1 Overview
    • 10.2.2 Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Online Channels
    • 10.3.1 Overview
    • 10.3.2 Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.2.2 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.2.3 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.2.3.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.2.4 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.2.4.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.2.5 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.2.5.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.2.6 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.2.6.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.7 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.2.1 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.2.7.2.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.2.7.2.3 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.2.7.2.4 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.2.7.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.3.1 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.2.7.3.2 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.2.7.3.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.2.7.3.4 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.2.7.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.4.1 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.2.7.4.2 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.2.7.4.3 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.2.7.4.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.3 Europe
    • 11.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.3.2 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.3.3 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.3.3.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.3.4 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.3.4.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.3.5 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.3.5.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.3.6 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.6.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.7 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.2.1 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.2.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.2.3 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.2.4 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.3.1 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.3.2 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.3.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.3.4 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.4.1 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.4.2 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.4.3 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.4.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.5 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.5.1 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.5.2 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.5.3 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.5.4 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.6 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.6.1 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.6.2 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.6.3 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.6.4 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.7 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.7.1 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.7.2 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.7.3 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.7.4 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.4.3.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.4.4 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.4.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.4.5 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.4.5.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.4.6 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.6.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.7 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.2.1 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.2.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.2.3 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.2.4 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.3.1 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.3.2 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.3.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.3.4 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.4.1 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.4.2 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.4.3 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.4.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.5 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.5.1 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.5.2 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.5.3 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.5.4 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.6 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.6.1 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.6.2 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.6.3 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.6.4 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.7 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.7.1 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.7.2 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.7.3 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.7.4 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.5.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.5.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.5.3.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.5.4 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.5.4.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.5.5 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.5.5.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.5.6 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.5.7 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.2.1 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.2.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.2.3 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.2.4 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.7.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.3.1 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.3.2 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.3.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.3.4 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.7.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.4.1 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.4.2 South Africa: Non-steroidal Anti-inflmatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.4.3 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.4.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.7.5 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.5.1 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.5.2 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.5.3 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.5.4 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.6 South and Central America
    • 11.6.1 South and Central America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.6.2 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.6.3 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.6.3.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.6.4 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.6.4.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.6.5 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.6.5.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.6.6 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.6.6.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.6.7 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.2.1 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.6.7.2.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.6.7.2.3 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.6.7.2.4 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.6.7.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.3.1 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.6.7.3.2 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.6.7.3.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.6.7.3.4 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.6.7.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.4.1 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.6.7.4.2 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.6.7.4.3 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.6.7.4.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Market Share Analysis, 2024

13. Industry Landscape

  • 13.1 Expansion
  • 13.2 New Product Development
  • 13.3 Other Business Strategies

14. Company Profiles

  • 14.1 Pfizer Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Bayer AG
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Dr. Reddy's Laboratories Ltd
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Glenmark Pharmaceuticals Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Sun Pharmaceutical Industries Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Novartis AG
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hikma Pharmaceuticals Plc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Boehringer Ingelheim International GmbH
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Viatris Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Haleon Plc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary of Terms
  • 15.2 About The Insight Partners

List Of Tables

  • Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation
  • Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 12. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 13. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 14. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 15. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 16. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 17. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 18. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 19. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 20. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 21. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 22. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 23. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 24. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 25. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 26. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 27. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 28. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 29. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 30. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 31. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 32. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 33. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 34. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 35. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 36. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 37. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 38. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 39. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 40. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 41. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 42. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 43. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 44. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 45. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 46. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 47. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 48. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 49. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 50. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 51. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 52. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 53. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 54. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 55. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 56. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 57. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 58. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 59. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 60. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 61. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 62. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 63. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 64. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 65. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 66. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 67. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 68. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 69. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 70. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 71. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 72. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 73. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 74. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 75. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 76. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 77. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 78. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 79. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 80. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 81. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 82. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 83. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 84. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 85. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 86. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 87. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 88. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 89. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 90. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 91. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 92. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 93. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 94. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 95. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 96. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 97. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 98. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 99. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 100. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 101. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 102. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 103. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 104. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 105. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 106. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 107. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 108. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 109. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 110. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 111. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 112. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 113. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 114. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 115. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 116. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 117. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 118. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 119. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 120. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 121. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 122. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 123. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 124. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 125. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 126. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 127. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 128. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 129. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 130. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 131. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 132. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 133. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 134. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 135. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 136. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 137. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 138. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 139. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 140. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 141. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 142. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 143. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 144. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 145. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 146. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 147. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 148. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 149. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 150. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 151. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 152. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 153. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 154. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 155. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 156. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 157. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 158. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 159. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 160. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 161. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 162. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 163. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 164. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 165. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 166. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 167. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 168. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 169. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 170. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 171. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 172. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 173. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 174. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 175. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 176. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 177. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 178. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 179. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 180. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 181. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 182. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 183. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 184. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 185. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 186. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 187. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 188. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 189. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 190. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 191. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 192. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 193. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 194. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 195. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 196. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 197. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 198. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 199. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 200. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 201. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 202. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 203. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 204. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 205. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 206. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 207. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 208. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 209. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 210. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 211. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 212. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 213. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 214. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 215. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 216. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 217. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 218. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 219. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 220. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 221. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 222. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 223. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 224. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 225. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 226. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 227. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 228. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 229. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 230. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 231. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 232. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 233. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 234. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 235. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 236. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 237. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 238. Heat Map Analysis by Key Players
  • Table 239. Glossary of Terms, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

List Of Figures

  • Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021-2031
  • Figure 5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Drug Class (2024 and 2031)
  • Figure 6. Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Route of Administration (2024 and 2031)
  • Figure 9. Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Indication (2024 and 2031)
  • Figure 13. Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 18. Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 22. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 23. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 24. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 25. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 26. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 27. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 28. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 32. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 33. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 34. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 35. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 36. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 37. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 44. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 45. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 46. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 47. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 48. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 49. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 51. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 52. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 56. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 57. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 58. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 59. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 60. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 61. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 65. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 66. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 67. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 68. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 69. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 70. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 71. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 72. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 73. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 74. Company Market Share Analysis, 2024